BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3923162)

  • 1. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R; Slaughter D
    Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
    Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
    Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
    D'Elia JA; Aslani M; Schermer S; Cloud L; Bothe A; Dzik W
    Ren Fail; 1987; 10(2):107-13. PubMed ID: 3120247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.